Immuneering Corp (IMRX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $218.48M | +427.9% |
| 2024 | $41.39M | -54.3% |
| 2023 | $90.58M | -17.5% |
| 2022 | $109.85M | -29.6% |
| 2021 | $155.98M | +793.8% |
| 2020 | -$22.48M | -244.4% |
| 2019 | -$6.53M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $218.48M | +427.9% |
| 2024 | $41.39M | -54.3% |
| 2023 | $90.58M | -17.5% |
| 2022 | $109.85M | -29.6% |
| 2021 | $155.98M | +793.8% |
| 2020 | -$22.48M | -244.4% |
| 2019 | -$6.53M | — |